These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.
    Author: Rivers JK.
    Journal: Skin Therapy Lett; 2004 Jan; 9(1):1-3. PubMed ID: 14716439.
    Abstract:
    Actinic Keratoses (AKs) are epidermal skin lesions that have the potential to develop into squamous cell carcinoma. Many of the treatment options available can cause discomfort, pain or skin irritation. Topical 3% diclofenac in 2.5% hyaluronan gel (Solaraze, Bioglan Pharma) is a relatively new treatment that has been shown to be effective and well tolerated for the treatment of AKs.
    [Abstract] [Full Text] [Related] [New Search]